BridgeBio Oncology Therapeutics, Inc. (BBOT)

NASDAQ: BBOT · Real-Time Price · USD

9.90

-0.18 (-1.79%)

At close: Sep 5, 2025, 4:00 PM

10.23

+0.33 (3.33%)

After-hours: Sep 5, 2025, 7:59 PM EDT

BBOT Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023
Period Ending	Jun '25 Jun 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
Selling, General & Admin	9.27	7.76	8.49
Research & Development	85.5	73.11	56.29
Operating Expenses	94.77	80.86	64.77
Operating Income	-94.77	-80.86	-64.77
Interest & Investment Income	8.08	6.38	0.07
Other Non Operating Income (Expenses)	-0.81	0.21	-
Pretax Income	-87.5	-74.28	-64.7
Net Income	-87.5	-74.28	-64.7
Net Income to Common	-87.5	-74.28	-64.7
Shares Outstanding (Basic)	0	0	0
Shares Outstanding (Diluted)	0	0	0
Shares Change (YoY)	-	16.36%	-
EPS (Basic)	-268.56	-511.80	-518.73
EPS (Diluted)	-268.56	-511.80	-518.73
Free Cash Flow	-81.31	-55.08	-52.49
Free Cash Flow Per Share	-249.57	-379.51	-420.87
EBITDA	-94.55	-80.66	-64.68
D&A For EBITDA	0.23	0.21	0.09
EBIT	-94.77	-80.86	-64.77

Source: S&P Global Market Intelligence. Standard template. Financial Sources.